Total Return chart Taiwan Bio Therapeutics Co., Ltd

Equities

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-06-30 EDT			5-day change	1st Jan Change
41.85 ^TWD	+1.95%		+2.45%	+22.01%

03-12	TRACT Therapeutics and Taiwan Bio Therapeutics Announce to Launch Phase 2 Clinical Trial Investigating Ability of Treg Therapy to Reduce Use of Immunosuppressant Drugs in Living Donor Kidney Transplant Recipients	CI
2023	Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.